Pacs Group, INC Form 4 insider transactions

Joshua Jergensen, President & COO of PACS Group, Inc., sold 40,000 shares of common stock on August 12, 2026.

Joshua Jergensen, President & COO of PACS Group, Inc., sold 40,000 shares of common stock on July 15, 2026.

Mark Hancock, a Director and 10% owner of PACS Group, Inc., sold 13,628 shares of common stock on July 14, 2026.

Mark Hancock, a Director and 10% Owner of PACS Group, Inc., reported the sale of common stock totaling 25,304 shares through a pre-arranged Rule 10b5-1 trading plan.

Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc., has reported the sale of company stock totaling over 14,000 shares across three transactions executed between July 1st and July 6th, 2026, under a pre-established Rule 10b5-1 trading plan.

PACS Group, Inc. Director Mark Hancock reported transactions involving the sale of common stock, executed under a pre-arranged Rule 10b5-1 trading plan.

Director Patrick Conway acquired 4,287 shares of PACS Group common stock through restricted stock units.

Jacqueline Millard, a Director at PACS Group, Inc., acquired 4,287 shares of common stock through restricted stock units.

Director Taylor Leavitt acquired 4,287 shares of PACS Group common stock through restricted stock units.

Evelyn Dilsaver, a Director at PACS Group, Inc., reported the acquisition of 4,287 shares of common stock on July 1, 2026, as part of a restricted stock unit grant.

PACS Group, Inc. Director Mark Hancock reported the sale of common stock totaling over 200,000 shares through a pre-arranged 10b5-1 trading plan.

Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc., reported a sale of 15,000 shares of common stock executed on June 25, 2026, under a pre-arranged Rule 10b5-1 trading plan.

PACS Group, Inc. Director Mark Hancock has sold a significant number of shares through a pre-arranged trading plan, indicating a planned divestment strategy.

Director Patrick Hugh Conway was granted 4,660 restricted stock units in PACS Group, Inc. as part of standard equity compensation.

Director Taylor S. Leavitt was granted 4,660 restricted stock units as part of his compensation package with PACS Group, Inc.

Director Jacqueline Millard was granted 4,660 restricted stock units in PACS Group, Inc. as part of a standard equity award.

Director Evelyn Dilsaver was granted 4,660 restricted stock units in PACS Group, Inc. as part of an equity compensation arrangement.

Chief Legal Officer John Todd Mitchell sold 80,152 shares of PACS Group common stock via a pre-arranged 10b5-1 trading plan.

PACS Group CFO Carey Hendrickson was granted 48,426 restricted stock units vesting over three years.

Chief Accounting Officer Michelle Renee Lewis reported the withholding of 24,691 shares of PACS Group common stock to satisfy tax obligations.

Chief Legal Officer John Todd Mitchell reported the withholding of 66,471 shares to satisfy tax obligations upon the vesting of restricted stock units.

President and COO Joshua Jergensen disposed of 197,525 shares of PACS Group common stock to satisfy tax obligations.

PACS Group's Chief Compliance Officer, Kelly Priegnitz, was granted 8,203 restricted stock units, vesting over three years.

PACS Group, Inc.'s Chief Human Resources Officer, Trent Dean Bingham, was granted 14,649 restricted stock units vesting over three years.

PACS Group's Chief Accounting Officer, Michelle Renee Lewis, was granted 35,159 restricted stock units vesting over three years.

PACS Group's Chief Legal Officer, John Todd Mitchell, was granted 82,039 restricted stock units vesting over three years.

PACS Group's President & COO, Joshua Jergensen, received a grant of 146,498 restricted stock units, aligning executive incentives with shareholder interests.

Mark Hancock, a Co-Founder, Interim CFO, and Executive Vice Chair of PACS Group, Inc., was granted 98,154 restricted stock units.

PACS Group, Inc. Co-Founder, CEO, and Chairman Jason Hulse Murray was granted 234,397 restricted stock units (RSUs) on March 24, 2026, which will vest over three years.

PACS Group's President & COO, Joshua Jergensen, sold 36,335 shares of common stock for approximately $1.24 million on March 13, 2026.